Published Date:2023-06-01 Original Link:https://www.onenessbio.com/en/news_detail223_3.htm No 1 Date of announcement 2023/06/01 Time of announcement  17:35:53 Subject Oneness Biotech Co., Ltd. receives the United States patent on the producing recombinant glycoproteins with modified glycosylation. To which item it meets paragraph 53 Date of events 2023/06/01 Statement Date of occurrence of the event:2023/06/01 Company name:ONENESS BIOTECH CO., LTD....Read More

Published Date:2023-05-31 Original Link:https://www.onenessbio.com/en/news_detail222_3.htm No 1 Date of announcement 2023/05/31 Time of announcement 23:56:02 Subject Oneness submitted an IND to US FDA for a phase II clinical trial on the broad-spectrum anti-SARS-CoV-2 siRNA (SNS812) co-developed with Microbio (Shanghai) To which item it meets paragraph 10 Date of events 2023/05/31 Statement Product:SNS812, a broad-spectrum siRNA against...Read More

Published Date:2023-05-30 Original Link:https://www.onenessbio.com/en/news_detail221_3.htm No 1 Date of announcement 2023/05/30 Time of announcement 16:34:50 Subject Announced The Board of Directors’ resolution of 2023 that the related matters of ex-rights and ex-dividend. To which item it meets paragraph 14 Date of events 2023/05/30 Statement Date of the resolution by the board of directors or shareholders’ meeting,...Read More

Published Date:2023-05-23 Original Link:https://www.onenessbio.com/en/news_detail220_3.htm No 1 Date of announcement 2023/05/23 Time of announcement 16:28:00 Subject Oneness announces on behalf of Cotton Field Organic Farm Inc., a major subsidiary, for shareholders’ meeting important resolutions of the 2023 To which item it meets paragraph 18 Date of events 2023/05/23 Statement Date of the shareholders’ meeting:2023/05/23 Important resolutions...Read More

Published Date:2023-05-11 Original Link:https://www.onenessbio.com/en/news_detail219_3.htm No 1 Date of announcement 2023/05/11 Time of announcement 16:47:43 Subject The Company’s 2023Q1 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2023/05/11 Statement Date of the board of directors submitted or approved:2023/05/11 Date of the audit committee...Read More

Published Date:2023-05-08 Original Link:https://www.onenessbio.com/en/news_detail218_3.htm No 1 Date of announcement 2023/05/08 Time of announcement 17:20:41 Subject Oneness Attends the 9th International Symposium on Diabetic Foot 2023 (ISDF2023) To which item it meets paragraph 12 Date of events 2023/05/10 Statement Date of institutional investor conference:2023/05/10 Time of institutional investor conference:16:45 (TPE time) Location of institutional investor conference:The...Read More

Published Date:2023-05-02 Original Link:https://www.onenessbio.com/en/news_detail217_3.htm No 2 Date of announcement 2023/05/02 Time of announcement 17:53:30 Subject The Phase 3 MRCT post-hoc analysis and the post-market hard-to-heal cases of the DFU new drug, Fespixon have been accepted for an oral presentation at EWMA 2023. To which item it meets paragraph 12 Date of events 2023/05/05 Statement Date...Read More

Published Date:2023-05-02 Original Link:https://www.onenessbio.com/en/news_detail216_3.htm No 1 Date of announcement 2023/05/02 Time of announcement 17:44:57 Subject Oneness Biotech Co., Ltd. receives a Singaporean patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2023/05/02 Statement Date of occurrence of the event:2023/05/02 Company...Read More

Published Date:2023-04-28 Original Link:https://www.onenessbio.com/en/news_detail225_4.htm No 1 Date of announcement 2023/04/28 Time of announcement 22:12:32 Subject Announcement of the Phase 1 clinical trial data of SNS812, a broad-spectrum antiviral siRNA for COVID-19 developed jointly by Oneness and Microbio (Shanghai) Co.,Ltd. To which item it meets paragraph 10 Date of events 2023/04/28 Statement Product:SNS812, a broad-spectrum siRNA...Read More

Published Date:2023-04-27 Original Link:https://www.onenessbio.com/en/news_detail215_4.htm No 1 Date of announcement 2023/04/27 Time of announcement 18:50:51 Subject Oneness was notified today that Bonvadis Cream for scar management has been granted import license in Europe. To which item it meets paragraph 10 Date of events 2023/04/27 Statement Product:Bonvadis Cream for scar management Mass production date:NA Effect on company...Read More